Postpartum Depression: Identification and Treatment in the Clinic Setting
- PMID: 32762926
- DOI: 10.1016/j.ogc.2020.05.001
Postpartum Depression: Identification and Treatment in the Clinic Setting
Abstract
Perinatal care, including the management of mental health issues, often falls under the auspices of primary care providers. Postpartum depression (PPD) is a common problem that affects up to 15% of women. Most women at risk can be identified before delivery based on psychiatric history, symptoms during pregnancy, and recent psychosocial stressors. Fortunately, there have been a variety of treatment studies using antidepressants, nonpharmacologic interactions, and most recently, allopregnanolone (Brexanolone) infusion that have shown benefits. The most commonly used screening scale, Edinburgh Postnatal Depression Scale, a 10-item self-rated scale, has been translated into a variety of languages.
Keywords: Antidepressants; Diagnosis; Postpartum depression; Prevalence; Psychotherapy.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure E.B. Kroska has no competing interests to report. Z.N. Stowe has received research support and consultation honorarium from GlaxoSmithKline, Pfizer, and Wyeth Corporations and received speakers honoraria from these companies and Eli Lilly and Forest Corporations, but none of these relationships since 2008. He has received clinical trial support from Janssen Pharmaceuticals and Sage Therapeutics in the past 24 months and has received salary and research support from the National Institutes of Health and the Centers for Disease Control and Prevention.
